Learn how we help
About the project
Abbott Laboratories is an American multinational medical devices and health care company, spanning pharmaceuticals, medical devices, diagnostic assays and nutritional products. With over 100,000 employees, global turnover is in excess of $40bn, with their glucose management FreeStyle product line representing 9% of total revenue.The growth in Diabetes Care revenue in 2020 and 2021 was mostly driven by the continued growth of FreeStyle Libre, Abbott’s continuous glucose monitoring system, internationally and in the U.S. In 2021, FreeStyle Libre sales reached $3.7 billion, which reflected a 36.8 percent increase compared to 2020, excluding the effect of foreign exchange. In 2020 its sales were $2.6 billion, which reflected a 42.6 percent increase, excluding the effect of foreign exchange, compared to 2019 when the sales totalled $1.8 billion.
Abbott’s third-quarter 2022 report shows worldwide sales of $10.4 billion in the corresponding period, raise of its full-year 2022 EPS guidance, and a strengthening of its position on the market with a new-gen FreeStyle Libre 3 system automatically delivering up-to-minute glucose readings via the smallest and tiniest in the world wearable sensor
Their success
The deployment of our automation testing capability helped Abbott grow their innovative and convenient Diabetes monitoring solution to a global community of physicians and their patients. Today, with a highly stable product with no localisation issues or critical bugs, FreeStyle Libre is actively used by over 4 million users who rely on the service to provide timely reporting of their blood glucose.We have been working on Libreview since the end of 2019. With an initial engagement of 5 automation testing engineers and a QA lead, Abbott requested a further 6 QA engineers based on the quality of service they received from us.
As an ambitious growth business, including new pushes into Taiwan, Slovakia and Egypt in 2022, Abbott are continually upscaling our team to cover its growing QA needs. We believe this is proof of our status as a reliable QA partner, treating the project as a development effort rather than a testing effort, anticipating the next steps and improvements, quickly responding to changes, proactively taking on current problems and addressing future issues. Our cooperation means that over 20 engineers now provide the QA service to Abbott.
